Project Grant 2225476

Award Date 10/1/22
Completion Date 9/30/26
Dollars Obligated $708K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30332, USA
Similar Awards
This Project Grant from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems Engineering Directorate will support $541,665 in research at The University of Iowa from October 2022 through September 2026. The grant aims to advance control of human induced pluripotent stem cell differentiation to retinal cells through genomic and microfluidic techniques. Researchers will develop genome-wide methods leveraging cell differentiation properties...
This $500,000 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences, under the Biological Sciences federal grant program (CFDA 47.074), will support research to develop an end-to-end continuous manufacturing process for cell therapies using robotics and microfluidic technologies. The Georgia Tech Research Corporation will receive funding to create a more integrated workflow based on microfluidic device-enabled genetic engineering, cell expansion, and...
This $564,510 National Science Foundation project grant under the Biological Sciences program (CFDA 47.074) will develop computational methods and tools to learn mechanisms in cell differentiation and development from complex, high-dimensional single-cell multi-omics data. The Georgia Tech Research Corporation will receive funding from September 1, 2022 to August 31, 2027 to analyze single-cell RNA sequencing, genome, chromatin accessibility, protein abundance and spatial location data. The...
This $1,000,000 National Science Foundation project grant supports research at the University of Wisconsin-Madison to develop single cell-level programming of human induced pluripotent stem cell differentiation into chamber-specific cardiomyocytes. The goal is to generate cardiomyocytes from each chamber of the heart through precise control of Wnt and retinoic acid signaling at the single cell level via engineered genetic programs and superstructures. If successful, this approach could establish...
The National Eye Institute (NEI) awarded a $618,600 Project Grant under the Vision Research program (CFDA 93.867) to The University of Iowa to address two key challenges in the production of autologous stem cell-derived retinal tissue for regenerative medicine. Specifically, the grant supports research aims to: 1) develop an AI algorithm to select patient-derived induced pluripotent stem cell (iPSC) lines with a high propensity for retinal differentiation, eliminating resources wasted on lines...
The Georgia Tech Research Corporation was awarded a $1,077,799 project grant from the National Science Foundation Division of Molecular and Cellular Biosciences on September 1, 2021 to complete work by August 31, 2025. The grant falls under the Biological Sciences program (CFDA 47.074), which aims to promote progress in the biological sciences and strengthen the nation's scientific enterprise through increasing knowledge and enhancing understanding of major problems. Specifically, the grant will...
This $600,000 Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) aims to develop an integrated platform to better understand and address glaucoma-induced neurodegeneration. The key products and services to be delivered include: An injectable microbead-based in vivo flow occlusion model to replicate glaucoma-like conditions and achieve sustained intraocular pressure (IOP) elevation. A non-invasive electroretinogram (ERG) recording system to monitor...
This $125,805 Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to develop new cell sorting technologies that can identify and separate cells based on changes in the activity of naturally occurring light-emitting molecules like NAD(P)H. The goal is to enable label-free, rapid identification and purification of cell populations, with a focus on stem cells and their functional subsets. The research will create a single cell deposition module to...
This Project Grant award, funded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), aims to develop new sensing technologies for use in 3D cell cultures focused on neural organoids. The $750,000 grant, awarded on April 15, 2025, will support research activities at the University at Albany, SUNY Polytechnic Institute, Hudson Valley Community College, and Bronx Community College. Key objectives include: (1) building and testing conformal microelectrode arrays to...
This $210,899.12 Project Grant awarded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will support research to elucidate the gene regulatory networks that drive neural regeneration in the central nervous system. The overarching objective is to profile changes in gene regulation that cause retinal pigment epithelium (RPE) cells to lose their neural competency as they differentiate. Specific aims include interrogating transcription factor...

This four-year, $708,333 National Science Foundation project grant funds research at Georgia Tech Research Corporation to develop genetic and microfluidic technologies to direct the differentiation of human induced pluripotent stem cell-derived retinal organoids. Specifically, the researchers will apply genome-wide methods leveraging both cell differentiation and biomechanical properties to screen for pathways that regulate retinogenesis. Systems biology approaches will identify master regulators of retinal cell differentiation to validate effects on differentiated retinal subtypes. Additionally, cell separation coupled with novel markers aims to enhance production of rod and cone photoreceptor cells in appropriate proportions. This work supports the NSF Engineering Biology and Health Cluster's goal under the $47M Engineering program to foster innovation in engineering research applicable to improving health. The grant period began October 1, 2022 and is scheduled to conclude September 30, 2026.

Generated 1/7/24, 6:52 AM